Lanean...
LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature
BACKGROUND: For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa–carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa–carbidopa (LC). OBJECTIVES: To highlight LCIG effect in NMS a...
Gorde:
| Argitaratua izan da: | Brain Behav |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507541/ https://ncbi.nlm.nih.gov/pubmed/32677345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1757 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|